Mark is a principal in KPMG’s Strategy Practice focusing on Healthcare and Life Sciences. Mark has 20 years of experience in strategy, market research, acquisition integration, divestiture carve-out, process improvement, regulatory compliance, organizational effectiveness, and change management. Mark has experience in all aspects of life sciences, including pharmaceuticals, biotechnology, medical device, diagnostics, and healthcare distribution. Mark also leads KPMG’s initiatives and thought leadership in biosimilars. Mark’s recent publications include How to Complete and Win in a World with Biosimilarsand Medical Device Trends. Mark is a Board Member and Past President of the Cystic Fibrosis Foundation, Northern California.